AMY SNOW: Open Payments
NPI 1215912712 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,656 in 43 payments from 15 companies in 2025. Trend: 2023 $1,959 · 2024 $1,425 · 2025 $1,656
Food & beverage: $1,413Education: $243
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 10 | $337 |
| Janssen Biotech, Inc. | 4 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $214 |
| GENZYME CORPORATION | 5 | $195 |
| Regeneron Healthcare Solutions, Inc. | 3 | $147 |
| LEO Pharma Inc. | 2 | $88 |
| UCB, Inc. | 3 | $87 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| PFIZER INC. | 2 | $57 |
| Incyte Corporation | 2 | $54 |
Products named: DUPIXENT, Zoryve, TREMFYA, ILUMYA, Bimzelx, CIBINQO, OPZELURA, ANZUPGO.
Industry payments across OR — which companies pay providers there.
